Stock Information
Vertex Pharmaceuticals Inc (VRTX)
Ticker Symbol: VRTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $111,308.99 mil
Piotroski score: 5
PE Ratio: 28.0349
EPS (TTM): 15.3331
Revenue (TTM): $46.84 M
Dividend Yield: N/A%
ROE: 22.7%
Latest News
-
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
Sat, Apr 11, 2026 12:58 PM
-
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
Fri, Apr 10, 2026 9:50 PM
-
Did Halozyme’s Vertex Hypercon Licensing Deal Just Shift Halozyme Therapeutics’ (HALO) Investment Narrative?
Fri, Apr 10, 2026 6:12 PM
-
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Fri, Apr 10, 2026 1:00 PM
-
Morgan Stanley Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $612
Fri, Apr 10, 2026 12:12 PM
-
What to Expect From Vertex Pharmaceuticals’ Q1 2026 Earnings Report
Fri, Apr 10, 2026 10:37 AM
-
Vertex Pharmaceuticals (VRTX) Valuation Check After FDA Expands ALYFTREK And TRIKAFTA Use
Thu, Apr 9, 2026 2:14 AM
-
Undercovered Dozen: CVR Energy, Greystone Housing, Conagra Brands, And More
Wed, Apr 8, 2026 11:16 PM
-
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
Wed, Apr 8, 2026 10:00 PM
-
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Wed, Apr 8, 2026 1:00 PM
Key Financials
Financial data not available
